510(k) Report

510(k) · Cleared

Cleared

OxyGo Portable Oxygen Concentrator (1400-7000)

K252407510(k) TraditionalCleared Apr 23, 2026266-day reviewClass II21 CFR 868.5440

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Mv Life, LLC · CAW Generator, Oxygen, Portable

Cleared on Apr 23, 2026 as substantially equivalent to K230052 (Inogen, Inc., 2023) after a 266-day review. Its family tree reaches back 3 generations to 2021.

Decided
Apr 23, 2026
Review
266 days
Class
Class II
Product code
CAW
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K203086 (2021). No later device cites it as a predicate yet.

  1. Root · 3 generations backK203086 X-PLO2RBelluscura, LLC · 2021
  2. 2 generations backK222086 Inogen Rove 4 Portable Oxygen ConcentratorInogen · 2022
  3. 1 generation backK230052 Inogen Rove 6Inogen, Inc. · 2023
  4. This deviceK252407 OxyGo Portable Oxygen Concentrator (1400-7000)Mv Life, LLC · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K203086X-PLO2RBelluscura, LLC2021—
−2K222086Inogen Rove 4 Portable Oxygen ConcentratorInogen2022—
−1K230052Inogen Rove 6Inogen, Inc.2023—
0 (this device)K252407OxyGo Portable Oxygen Concentrator (1400-7000)Mv Life, LLC2026—
FIG. 1 — Lineage of K252407, 2021–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CAW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CAW device

  1. #1 K230052 Inogen Rove 6score 29.9 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K230052Inogen Rove 6
Summary page 5
…Class II Reviewing Panel: Anesthesiology Product Code: CAW Primary Predicate Device: K230052 – Inogen Rove 6 Portable Oxygen Concentrator Device Description: The OxyGo Portable Oxygen Concentrator is a Class 2, low risk,…
Inogen, Inc.2023—

Also cleared against K230052: 7 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 5 years and passes through 4 companies; a new generation was cleared every 1.8 years on median.
  • None of the 3 ancestors has a recall.
  • 7 other devices also cite its predicate K230052.

How does its category compare?

All CAW devices

CAW Generator, Oxygen, Portable: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · CAW

12in 2025

2007: 62008: 112009: 82010: 52011: 62012: 52013: 22014: 62015: 12016: 12017: 12018: 32019: 22020: 52021: 22022: 42023: 82024: 22025: 122026 (partial year): 6
2007high 12 (2025) · low 1 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CAW

178in 2025

2007: 143 days median2008: 90 days median2009: 193 days median2010: 133 days median2011: 174 days median2012: 148 days median2014: 277 days median2018: 203 days median2020: 224 days median2022: 458 days median2023: 261 days median2025: 178 days median2026 (partial year): 260 days median
2007high 458 (2022) · low 90 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CAW

1in 2025

2007: 12008: 32009: 22011: 12013: 22014: 22016: 12017: 12019: 22020: 12022: 22024: 5, 1 Class I2025: 1
2007high 5 (2024) · low 0 (2010)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · CAW

611in 2025

2007: 232008: 252009: 432010: 482011: 1672012: 3952013: 2,3092014: 24,5382015: 18,9732016: 3,1672017: 1072018: 1162019: 1202020: 1252021: 1942022: 3052023: 3572024: 4502025: 611
2007high 24,538 (2014) · low 23 (2007)2025

MAUDE reports naming product code CAW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20076143123
20081190325
20098193243
20105133048
201161741167
201251480395
20132—22,309
20146277224,538
20151—018,973
20161—13,167
20171—1107
201832030116
20192—2120
202052241125
20212—0194
202244582305
202382610357
20242—5 (1)450
2025121781611
202662600—

What is it indicated for?

The OxyGo Portable Oxygen Concentrator provides a high concentration of supplemental oxygen to

patients requiring respiratory therapy on a prescriptive basis. It may be used in home, institution, vehicle,

and other transport modalities. This device is to be used as an oxygen supplement and is not intended to be

life sustaining or life supporting.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K252407: OxyGo Portable Oxygen Concentrator (1400-7000).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K252407

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026